Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;83(6):1217-22.
doi: 10.1016/j.urology.2014.02.001. Epub 2014 Apr 6.

Maximal testosterone suppression in prostate cancer--free vs total testosterone

Kyle O Rove  1 , E David Crawford  2 , Massimo Perachino  3 , Juan Morote  4 , Laurence Klotz  5 , Paul H Lange  6 , Gerald L Andriole  7 , Alvin M Matsumoto  8 , Samir S Taneja  9 , Mario A Eisenberger  10 , Leonardo O Reis  11
Affiliations
Review

Maximal testosterone suppression in prostate cancer--free vs total testosterone

Kyle O Rove et al. Urology. 2014 Jun.

Abstract

Testosterone remains a key target in the treatment of advanced prostate cancer. The relationship of free testosterone to prostate cancer treatment and outcomes remains largely unexplored. A consensus of prostate cancer experts was convened in 2013 to review current knowledge surrounding relationship of total and free testosterone to prostate cancer, discuss the free hormone hypothesis, and highlight future avenues for therapeutics. Free testosterone may better reflect prostate cancer tissue androgen levels than serum total testosterone concentration. Free testosterone deserves more research regarding its relation to clinical outcomes.

PubMed Disclaimer

References

    1. Sharifi R, Bruskewitz RC, Gittleman MC, et al. Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer. Clin Ther. 1996;18:647–657. - PubMed
    1. Oefelein MG, Feng A, Scolieri MJ, et al. Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making. Urology. 2000;56:1021–1024. - PubMed
    1. Nishiyama T. Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature. Urol Oncol. 2014;32:38.e17–38.e28. - PubMed
    1. Reis LO. Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question. Endocr Relat Cancer. 2012;19:R93–R98. - PubMed
    1. Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin Chem. 1987;33:1372–1375. - PubMed

Publication types

MeSH terms